Chuhang Technology showcases industry-leading radar innovations at IAA 2023
MUNICH, GERMANY, Sept. 04, 2023 (GLOBE NEWSWIRE) -- Chuhang Technology ("Chuhang,"), a pioneer in millimeter-wave sensing radars, will exhibit a full range of new technology at the IAA Mobility trade show held between Sept. 4 to Sept. 8 in Munich, Germany. The highlight of these radar innovations is a new cabin sensing suite based on its 60 GHz vital sensor developed in partnership with emotion3D.
"We are thrilled to present the distillation of our hard work in the international spotlight,” said Chu Yongyan, Chief Executive Officer of Chuhang Technology. “IAA is one of the most prestigious gatherings of the transportation industry, and our presence here represents our dedication to enhancing the capabilities of next-generation radar.
Chuhang's attendance at IAA 2023 is the first time it has exhibited outside of China, notching a milestone in its international expansion. Founded in 2017, Chuhang has reached rapid success across its business verticals. It’s now poised to execute the next phase of its expansion strategy.
Chuhang specializes in the R&D, production and manufacturing of advanced sensing solutions, having developed a suite of active radar systems that offer superior reliability, compliance, cost-effectiveness, and ease of integration. It became China's first millimeter-wave radar technology company to receive investment from FORVIA, the merger between HELLA and Faurecia, and has successfully graduated from accelerator programs by Tencent and Nvidia.
Reliability, safety and integration underscore Chuhang’s commitment to proactively adhere to international standards. Its core products, the 60GHz vital sign radar, 77 GHz forward radar, and the 77 GHz corner radar, have all passed EU's CE certification, ready to meet the demands of next-generation vehicles. The Company's millimeter-wave radar chip, digital signal processing chipset, integrated antenna array, microcontroller unit and Autosar-based software architecture have all passed the ISO 26262 ASIL-B compliance. Led by Wogong Zhang, Chief Technology Officer and Co-Founder of Chunhang, the company has made significant contributions to the development of the ISO/PWI 13389 "Road vehicles — Test Method for Detection Performance of Millimeter-wave Radar," aiming to set an international standard for the testing millimeter-wave radar systems.
Chuhang has also made major investments across all organizational functions, especially its research and production capabilities, to increase its supply chain resilience and technological leadership. It has established research facilities in Stuttgart, Shanghai, and Anqing.
These effective strategic investments have enabled Chunhang to further accelerate its growth. The company completed its MMIC, PCB and path projection research and development in two years, and SOP ramp production in just one. And with a new IATF16949-certified production facility in Anqing capable of producing 1.8 million radar products annually, the company is poised to meet the scalability, reliability and stability volume requirements of any customer with its world-class manufacturing.
Chuhang has garnered the trust of major vehicle industry members, including Ninebot, Navinfo, APOLLO and many others. Having already supplied its products to more than 50 vehicle designs, Chuhang expects to ship nearly five million units to commercial and personal vehicles. Recently, Chuhang has jointly developed a multi-sensing solution for in-vehicle drowsiness detection, combining Chuhang's radar solution with eMotion 3D's CABIN EYE software.
Chuhang is also constantly expanding its vibrant partners network. It’s currently negotiating to be a supplier for a major German vehicle manufacturer, with products expected to be delivered in 2026. As it penetrates global markets, Chuang is committed to developing localized and targeted solutions to meet the specific needs of its international customers.
Finally, Chuhang is a champion of employee wellness and social responsibilities, having pooled extensive resources for employee growth and development. In addition to offering clear growth paths and comprehensive benefits, Chuhang has vast resources for talent development for employees of all levels.
About Chuhang Technology
Chuhang Technology is a startup established by a team previously based in Germany. The Company is dedicated to the development and production of 77 GHz to 79 GHz millimeter-wave (MMW) radar sensors for the Advanced Driving Assistance Systems (ADAS) and Automated Driving (AD) applications. Its products have been deployed in passenger and commercial vehicles to helps to enhance ADAS functions such as Blind Spot Detection System (BSD), Forward Collision Warning (FCW), Adaptive Cruise Control (ACC), and Automatic Emergency Braking (AEB), supporting the development of the worldwide AD system and Cooperative Vehicle Infrastructure System (CVIS) of Intelligent Connected Vehicles (ICVs). Chuhang has established headquarters in Jiangbei New Area, Nanjing, Jiangsu, PR. China, R&D centers in Stuttgart, Germany, and Shanghai, Hefei, Anhui, PR. Recently, it finished the SOP ramp-up phase at its new ATF16949-certified manufacturing facility with annual production capacity of 1,800,000 radars in Anqing, Anhui, China.
Learn more at en.Chuhang.tech.
Mobile Phone: Wang Bo +49 15152192552
AttachmentTo view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml.globenewswire.com, please give your consent at the top of this page.
About GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York
GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Subscribe to releases from GlobeNewswire by notified
Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from GlobeNewswire by notified
FDA Approves Biogen’s TOFIDENCE™ (tocilizumab-bavi), a Biosimilar Referencing ACTEMRA®29.9.2023 22:06:00 CEST | Press release
TOFIDENCE (BIIB800) becomes the first tocilizumab biosimilar to gain FDA approval in the United States FDA approval is based on a robust analytical, non-clinical and clinical data package comparing TOFIDENCE to the reference product ACTEMRA CAMBRIDGE, Mass., Sept. 29, 2023 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) announced that the U.S. Food and Drug Administration (FDA) has approved TOFIDENCE (tocilizumab-bavi) intravenous formulation, a biosimilar monoclonal antibody referencing ACTEMRA. The TOFIDENCE intravenous formulation is approved for the treatment of moderately to severely active rheumatoid arthritis, polyarticular juvenile idiopathic arthritis and systemic juvenile idiopathic arthritis. TOFIDENCE is the first tocilizumab biosimilar approved in the United States. Biosimilars are biologic products that have been demonstrated to have equivalent efficacy and comparable safety as the approved reference product, with the advantage that they may offer cost savings and promote
Monument Reports Fourth Quarter and Fiscal 2023 Results29.9.2023 21:26:28 CEST | Press release
Gross Revenue of US$12.39 Million and Cash Cost of US$917/Oz for Gold Sulphide Production and US$1,622/Oz for Gold Oxide Production VANCOUVER, British Columbia, Sept. 29, 2023 (GLOBE NEWSWIRE) -- Monument Mining Limited (TSX-V: MMY and FSE: D7Q1) “Monument” or the “Company” today announced its annual financial results for the year ended June 30, 2023. All amounts are in United States dollars unless otherwise indicated (refer to www.sedar.com for full financial results). Cathy Zhai, the President and CEO commented, “Fiscal 2023 was a milestone year for the Company with the gold sulphide project completed, and the flotation plant was put into production at the Selinsing Gold Mine in Malaysia. The commercial production has also been reached in August 2023 subsequent to the year end. It again demonstrates Monument has been able to deliver what’s been promised and now we are ready for the next corporate move.” Fiscal Year 2023 Highlights: Construction of the Selinsing sulphide flotation pla
Nokia Corporation: Repurchase of own shares on 29.09.202329.9.2023 20:00:00 CEST | Press release
Nokia Corporation Stock Exchange Release 29 September 2023 at 21:00 EEST Nokia Corporation: Repurchase of own shares on 29.09.2023 Espoo, Finland – On 29 September 2023 Nokia Corporation (LEI: 549300A0JPRWG1KI7U06) has acquired its own shares (ISIN FI0009000681) as follows: Trading venue (MIC Code)Number of sharesWeighted average price / share, EUR*XHEL319,5513.57CEUX58,3773.57AQEU11,0113.57TQEX4,7613.57Total393,7003.57 * Rounded to two decimals On 3 February 2022, Nokia announced that its Board of Directors is initiating a share buyback program under the authorization granted by Nokia’s Annual General Meeting on 8 April 2021 to return up to EUR 600 million of cash to shareholders in tranches over a period of two years. The second phase of the share buyback program in compliance with the Market Abuse Regulation (EU) 596/2014 (MAR), the Commission Delegated Regulation (EU) 2016/1052 and under the authorization granted by Nokia’s Annual General Meeting on 5 April 2022 started on 2 Januar
EPH European Property Holdings PLC announces Unaudited Interim Results for the Six Months to 30 June 2023 and appointment of Management Committee Members29.9.2023 19:00:00 CEST | Press release
29 September 2023, Limassol, Cyprus / Ad hoc announcement pursuant to Art. 53 LR BUSINESS HIGHLIGHTS FIRST HALF YEAR OF 2023 With an established portfolio of high-quality properties in prime locations in Europe occupied by tenants with strong credit ratings, combined with professional asset management, EPH European Property Holdings PLC (“EPH” or the “Company”) has demon-strated operational stability in the first six months of 2023, despite the ongoing market environment challenges. As a result, EPH not only achieved almost full occupancy throughout its European portfolio, it also increased rental income.The sale of the Company’s Russian portfolio was concluded in April 2023, following the Extraordinary General Meeting (held on 1 November 2022) at which the shareholders of EPH authorised the Board of Directors to sell EPH Group’s entire Russian property portfolio by way of a management buyout. Upon disposal of the Russian segment in the first half of 2023, the Company reclassified the
Oxurion Publishes First Half 2023 Results29.9.2023 19:00:00 CEST | Press release
Regulated Information Leuven, BELGIUM, Boston, MA, US –September 29, 2023 – 7.00PM CET – Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company developing next-generation standard of care ophthalmic therapies, with clinical stage assets in vascular retinal disorders, today published its financial and business update for the six-month period ending June 30, 2023. The half-year report is available in the “Investors” section of the Company’s website and can also be downloaded as a PDF. About Oxurion Oxurion (Euronext Brussels: OXUR) is a biopharmaceutical company developing next generation standard of care ophthalmic therapies, which are designed to improve and better preserve vision in patients with retinal disorders including diabetic macular edema (DME), the leading cause of vision loss in working-age people, as well as other conditions. Oxurion intends to play an important role in the treatment of retinal disorders, including the successful development of THR-149, its novel